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Abstract
Background: Day care centre (DCC) attendees play a central role in maintaining the circulation
of Streptococcus pneumoniae (pneumococcus) in the population. Exposure within families and within
DCCs are the main risk factors for colonisation with pneumococcal serotypes in DCC attendees.
Methods: Transmission of serotype specific carriage was analysed with a continuous time event
history model, based on longitudinal data from day care attendees and their family members. Rates
of acquisition, conditional on exposure, were estimated in a Bayesian framework utilising latent
processes of carriage. To ensure a correct level of exposure, non-participating day care attendees
and their family members were included in the analysis. Posterior predictive simulations were used
to quantify transmission patterns within day care cohorts, to estimate the basic reproduction
number for pneumococcal carriage in a population of day care cohorts, and to assess the critical
vaccine efficacy against carriage to eliminate pneumococcal transmission.
Results: The model, validated by posterior predictive sampling, was successful in capturing the
strong temporal clustering of pneumococcal serotypes in the day care cohorts. In average 2.7 new
outbreaks of pneumococcal carriage initiate in a day care cohort each month. While 39% of
outbreaks were of size one, the mean outbreak size was 7.6 individuals and the mean length of an
outbreak was 2.8 months. The role of families in creating and maintaining transmission was minimal,
as only 10% of acquisitions in day care attendees were from family members. Considering a
population of day care cohorts, a child-to-child basic reproduction number was estimated as 1.4
and the critical vaccine efficacy against acquisition of carriage as 0.3.
Conclusion: Pneumococcal transmission occurs in serotype specific outbreaks of carriage, driven
by within-day-care transmission and between-serotype competition. An amplifying effect of the day
care cohorts enhances the spread of pneumococcal serotypes within the population. The effect of
vaccination, in addition to reducing susceptibility to pneumococcal carriage in the vaccinated,
induces a herd effect, thus creating a counter-effect to the amplifying effect of the cohort.
Consequently, the critical vaccine efficacy against carriage, required for elimination of transmission,
is relatively low. Use of pneumococcal conjugate vaccines is expected to induce a notable herd
protection against pneumococcal disease.
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Background
Knowing transmission is key to understanding vaccine
prevention of diseases caused by the pneumococcus
(Streptococcus pneumoniae). The adoption of new pneumo-
coccal polysaccharide conjugate vaccines into national
vaccination programs has been indicated by their efficacy
in protecting the vaccinated individuals against invasive
pneumococcal disease [1-4]. However, the most compel-
ling reason for their widespread use may lie with indirect
protection (herd immunity) that these vaccines provide to
the non-vaccinated part of the population [5-7]. This
means that a considerable proportion of prevented cases
of disease may result from reduced transmission of
asymptomatic nasopharyngeal carriage of pneumococci
in the population [8]. Such indirect protection is based on
the ability of the conjugate vaccines to reduce acquisition
of pneumococcal carriage [9,10], a pre-requisite of pneu-
mococcal disease.
Transmission of pneumococcal carriage is particularly
efficient among children, both in families and day care
facilities [11,12]. A number of studies have attempted to
quantify the effect of exposure to pneumococci in terms of
surrogate measures, such as family size, number of sib-
lings, crowding, attendance to day care, or weekly hours
spent in day care [13-15]. By contrast, only few studies
have quantified direct exposure to carriers of pneumo-
cocci in a serotype specific manner. The family studies that
have recorded carriage in all family members reveal a
higher intensity of transmission among family members
in comparison to acquisition from the general commu-
nity [16-19]. Similar results apply to children with close
contacts in school classes [20]. In all these studies expo-
sure to pneumococcal carriage had been measured in one
mixing group only, the family or the school class.
Enhanced transmission in families and day care facilities
implies that transmission in the whole population occurs
through micro-epidemics, i.e., temporally and spatially
localised outbreaks of carriage in these "mixing" groups.
Theoretical analyses have shown that groups with inten-
sive within-group transmission induce an amplifying
effect on transmission in the population [21]. In fact,
empirical data and simulation models have emphasized
the role of day care centres enhancing pneumococcal cir-
culation in the population [15]. The amplifying effect of
the mixing groups can be characterised by the average size
of the outbreak, where the relevant measure of size is the
total number of episodes of carriage during a single micro-
epidemic of carriage [cf. [21]]. The outbreak size has bear-
ing on the transmission potential of pneumococcal car-
riage, which eventually translates to the vaccination effort
needed to stop transmission in a population (cf. [22,23]).
The notion of outbreaks of pneumococcal carriage is
strengthened by the observation that different pneumo-
coccal serotypes or strains may dominate temporally and
locally in different day care facilities [24-26]. It is an inter-
esting question to which extent such patterns in pneumo-
coccal carriage are determined by chance alone in a net of
inter-connected clusters (day care groups and families),
with different intensities of transmission within day care
groups and the general population. Alternatively, the pat-
tern could at least partly reflect intra-species competition
between different serotypes.
In this study we report a novel analysis of pneumococcal
transmission. The analysis is based on a data set that to
our knowledge is the first to measure direct exposure to
pneumococci within families and day care facilities in the
same study cohort. Based on these data, we have previ-
ously shown that exposure to pneumococci both within
day care centres and within family are important risk fac-
tors for acquisition of carriage in day care attendees [26].
Using statistical modeling, we now quantify the impor-
tance of the two mixing groups for pneumococcal trans-
mission on the individual and population levels. We
assess the importance of transmission vs. between-sero-
type competition in producing the observed patterns of
carriage. We then treat pneumococcal transmission as out-
breaks of carriage, occurring in inter-related groups of day
care attendees. Based on this, we derive an estimate of the
group-to-group basic reproduction number for a single
serotype, describing the amplifying effect of within-group
transmission. Finally, we assess the critical vaccine efficacy
against acquisition to obtain herd immunity threshold,
i.e., to eliminate pneumococcal carriage, and discuss the
implications of this for pneumococcal disease.
Methods
The empirical data
The data have been described in detail elsewhere [26].
Briefly, all attendees with their family members and the
employees in three day care centres (DCCs) in the Tam-
pere area, Finland, were invited to participate in a longitu-
dinal study of pneumococcal carriage. Altogether, 213
individuals consisting of 61 day care attendees (59 index
children, and 2 siblings who entered the DCC later during
the study), 29 siblings, 86 family members > 18 years of
age, and 37 employees, were enrolled as study partici-
pants. In the three DCCs, the 25, 18 and 18 attendees
belonged to 20, 13 and 12 families, respectively. The
mean age of the attendees in the beginning of the study
was 4.1 years (range 1.2–6.6). The attendees account for
74%, 26% and 40% of the mean number of children (34,
69, and 45) attending the three DCC's. The term day care
cohort refers to all individuals connected to a DCC, includ-
ing the non-participants.BMC Infectious Diseases 2009, 9:102 http://www.biomedcentral.com/1471-2334/9/102
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During the follow-up between September 2001 and May
2002, nasopharyngeal (NP) samples of pneumococcal
carriage were collected from the study participants at 10
monthly visits. For most of the 213 participants the data
are almost complete: 87% of the individuals have 9 or 10
NP samples. In particular, missing data are few in the par-
ticipating families. Altogether 1941 samples were taken
from the individuals. Each sample comprises of the calen-
dar time of sampling, the age of the individual at sam-
pling, pneumococcal carriage (yes/no) and, in case of
carriage, the serotype of the isolate. In addition, the con-
tact groups (family, DCC) for each individual are known.
Table 1 summarises the data as episodes of carriage. The
reported numbers of participants that had antibiotic treat-
ment during the month preceding the sample was 54
(9.6% of the samples) in day care attendees, 25 (8.9%) in
siblings, 38 (4.8%) in family members > 18 years of age,
and 26 (7.5%) in day care employees.
Statistical methods
Notations and Definitions
The time of origin tmin is defined as the day before the first
NP sample in the data was taken. At any time t, the state
of individual i is one of the ns + 1 possible states, i.e., the
individual is either a carrier of one of ns serotypes, si(t) ∈
{1,...,ns}, or is a non-carrier, si(t) = 0. The process
, r,s = 1,...,ns, r ≠ s, counts the number of times the
individual has moved from state r to state s since tmin by
time t. Further, for a study cohort of n individuals the his-
tory of the n × (ns + 1) × ns counting processes   at
time t is denoted by Ht.
Transmission model
Acquisition and clearance of pneumococcal serotypes is
modelled through the following stochastic intensities for
processes :
where   is the indicator of individual i being in state
r at time t. The model considers two age groups; adults
(age a(i) ≤ 7 years) and children (a(i) < 7). The rate for
individual i is given by
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Table 1: Numbers of episodes of pneumococcal carriage in the three day care cohorts for day care attendees and for all participants.
Day care attendees (N = 61) All participants (N = 213)
Serotype DCC1 DCC2 DCC3 DCC1 DCC2 DCC3
9V 15 0 0 21 0 0
1 8 C 0 0 1 3 002 0
39 2 6 1 1 2 6
19F 0 8 0 1 14 1
1 5 B / C 2 4 5 366
1 1 A 1 2 3 147
1 9 A 7 0 0 800
3 5 F 3 2 0 341
1 4 0220 4 3
6 B 1101 4 1
2 2 0200 4 0
3 3 2003 0 0
3 8 2002 0 0
6 A 1101 1 0
9 N 0010 1 1
1 0 1001 0 0
1 6 1001 0 0
1 8 B 0 1 0 010
3 5 B 0 0 1 001
7 0 0 1 001
Non-typables 0 0 0 0 3 3
T o t a l 4 52 33 05 7 4 8 5 1
Clustering of carriage is most evident for serotypes 9V, 18C, and 19A, each being the dominant type in one DCC and not detected in the two other 
DCCs. Serotype specific episodes of pneumococcal carriage were constructed from the observed data by combining consecutive samples of the 
same serotype into episodes.BMC Infectious Diseases 2009, 9:102 http://www.biomedcentral.com/1471-2334/9/102
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Here   is the baseline rate of acquisition of serotype
s in a non-carrying child. To account for possible compe-
tition between pneumococcal serotypes in colonising the
host, a competition parameter φ ≥ 0 is used to scale the
rate of acquisition rate in an individual already carrying
another serotype. For a carrying child, tacq is the acquisi-
tion time of the ongoing episode of carriage, and α0(t -
tacq) = ρμ(μ(t - tacq))ρ-1, for ρ = 3, is the clearance rate (the
intensity function of a Weibull distribution) at time t - tacq
after acquisition. To account for differences between chil-
dren and adults the acquisition rates are multiplied with
ηa(i) = η1(a(i) ≥ 7) + 1(a(i) < 7), where η is the relative
acquisition rate in adults versus children. Similarly, the
clearance rate is multiplied with δa(i) = δ1(a(i) ≥ 7) + 1(a(i)
< 7), where δ is the relative clearance rate in adults versus
children.
In addition to including a community force of infection κ,
the baseline rate of acquisition in individual i at time t
takes into account serotype specific exposure within the
two mixing groups (family of size   and DCC of size
):
Thus, the baseline rate depends on the number of carriers
of serotype s in the individual's family ( ) and day
care centre ( ) at time t. Here   is the
rate at which a family member carrying serotype s trans-
mits carriage to a non-carrying susceptible family member
(similarly for the rate βdcc within the DCC). The second
(DCC) term is included in the acquisition rates of the
DCC attendees and employees only.
Hierarchical model
Making likelihood-based inference about the model
parameter θ = {βfam, βdcc, κ, μ, φ, η, δ} requires knowing
the exact event times and types (i.e. specific transitions).
However, the data consist of monthly samples only. The
problem was tackled by adopting a Bayesian latent proc-
ess approach, where using a Markov chain Monte Carlo
(MCMC) algorithm the space of possible carriage histories
Ht, i.e., that of latent processes consistent with the
observed data, was effectively sampled to produce esti-
mates of the unknown parameters (see Appendix)
[16,20]. Parameter estimates are given in terms of their
posterior means and 90% credibility intervals (90% CI).
Posterior predictive model validation and description of outbreaks
Transmission of carriage of 13 serotypes in a single day
care cohort was simulated, based on model (1) and sam-
ples from the posterior distribution of the model parame-
ters. The simulated day care cohort consisted of 50 DCC
attendees (children) and their family members (13 fami-
lies containing two day care attendees and two adults, and
24 families containing one day care attendee and three
adults). The posterior predictive simulations were used
A. to validate the model by comparing the posterior
prediction of the serotype distribution to the actually
observed distribution,
B. to quantify transmission patterns, i.e., who infected
whom within the cohort, by monitoring exposure at
each acquisition, and
C. to characterise outbreaks of pneumococcal carriage
by monitoring individual outbreaks for the total
number of episodes during one outbreak and the
duration of outbreak.
After a sufficient burn-in period of 1000 days, carriage
processes for cases A and B were followed for 270 days,
and until the end of outbreak for case C. An outbreak was
defined as the time interval from the first acquisition of a
specific serotype in the cohort until its (temporary) disap-
pearance from the cohort. In case A the model validation
was based on 10 evenly spaced samples gathered from
each day care attendee. To account for possible bias in the
observed serotype distribution, due to incomplete sam-
pling (i.e. missing data), the validation was repeated
based on a sub-sample of 20 DCC attendees. In case B, the
total number of acquisitions was divided into those from
the day care centre, the family, or the community in pro-
portions of exposure from the three sources. The results
are based on 1000 posterior predictive simulations.
Transmission potential and the critical vaccine efficacy
For any given serotype, the potential of within-group out-
breaks to sustain transmission in the whole population is
characterized by the average number of infectious con-
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tacts emanating from a single outbreak [21], the so called
group-to-group reproduction number R*. In the present
context, this value can be approximated by R* = λsD,
where λ is the serotype specific rate at which day care
attendees infect other day care attendees in the commu-
nity, D is the mean duration of a carriage episode in a day
care attendee, and s is the average number of carriage epi-
sodes in day care attendees in an outbreak originating
from a single carrying DCC attendee in a initially suscep-
tible (i.e. non-carrying) day care centre in the absence of
competing serotypes, and in the absence of community
force of infection.
An approximation to rate λ can be inferred from the sta-
tionary prevalence of day care attendees in the commu-
nity, and the pneumococcal acquisition rate from the
community (κ), assuming homogeneous mixing on the
population level. Specifically, if the prevalence of carriage
in day care attendees is p (~0.25), the serotype specific
community rate can be expressed as λ = 13 κ/p. Posterior
predictive simulations based on a day care cohort of size
50 (with a similar structure as above) were used to esti-
mate s. The simulations were performed by colonising a
random child in an initially susceptible cohort and then
recording the size of the outbreak. In total 5000 simula-
tions were performed.
Let  ν  denote the vaccine efficacy, i.e., the percentage
reduction in the rate of acquisition for a specific serotype.
The effective post-vaccination group-to-group reproduc-
tion number is then given by  , where sv
is corresponding average number of carriage episodes
under vaccination. The critical efficacy νc is the solution to
the nonlinear equation  . By applying the idea of
proliferation of carrying individuals (day care attendees)
in a community of day care centres (cf. [27]), one can infer
that the individual-to-individual basic reproduction
number for a pneumococcal serotype is give by (1 - νc)-1.
Results
Prevalence of pneumococcal carriage
The 90% interval of the posterior predictive prevalence of
pneumococcal carriage in children in a DCC of size 50,
calculated from 10 monthly samples was [21%, 46%]
with mean value 33%. For a sub-sample of 20 DCC
attendees the corresponding interval was [21%, 48%],
which is in line with the observed prevalence in the three
centres (27%, 26%, and 23%). Further, in the sub-sample
of 20 DCC attendees on a single sampling round the 90%
interval for the posterior predictive prevalence was [10%,
60%], also comparing well with the observed prevalence
that varied between 9% and 56%.
Community acquisition and the effect of competition
The posterior mean rate of acquisition from the commu-
nity (κ) was 0.0059 per month per serotype in a non-car-
rying child (90% CI [0.0043, 0.0078])(Table 2). The
posterior mean of the competition parameter (θ) was 0.68
Rs D nn nl
∗ =− () 1
Rn
∗ =1
Table 2: Estimates of the model parameters.
Model parameter Posterior mean 5% quantile 95% quantile
Community acquisition rate κ
(per month)
0.0059 0.0043 0.0077
Family transmission rate βfam
(per month)
0.36 0.23 0.52
DCC transmission rate βdcc
(per month)
0.53 0.38 0.71
Clearance rate μ
(per month)
0.69 0.64 0.75
Competition parameter θ 0.68 0.35 1.10
Relative susceptibility η
(adults vs. children)
0.41 0.28 0.58
Relative clearance rate δ
(adults vs. children)
1.23 1.06 1.41
The table presents the mean as well as the 5 and 95 percent quantiles of the marginal posterior distributions of the 7 model parametersBMC Infectious Diseases 2009, 9:102 http://www.biomedcentral.com/1471-2334/9/102
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(90% CI [0.35, 1.10]), indicating reduced ability of new
strains to occupy an already colonised nasopharynx.
Within-family and within day care acquisition
The posterior mean within-family transmission rate (βfam)
in children (age < 7 years) was 0.37 per month (90% CI
[0.23 0.52]). Adults (≥ 7 years) were less susceptible to
acquisition, with a relative transmission rate of 0.41 (90%
CI [0.28 0.58]). For a carrying child, it thus takes 4.5
months on average to infect another family member in a
family of one susceptible (child) sibling and two suscepti-
ble adults. The within-DCC transmission rate (βdcc) was
similar to the within-family rate, with posterior mean
0.53 per month (90% CI [0.38, 0.71]). However, because
the group size is larger than in the family, this corresponds
to an average of only 1.9 months for a carrying child to
infect another child in a totally susceptible DCC.
According to posterior predictive simulations of the trans-
mission model in a DCC of size 50, 65% of acquisitions
in day care attendees were from fellow day care attendees,
25% from the community, and only 10% from family
members. In introduction of a new serotype into the fam-
ily, in 82% of the cases the introductory individual was a
day care attendee, and in 71% of these instances the
acquisition had been from a fellow DCC attendee.
Clearance of carriage
The posterior mean rate (μ) of clearing pneumococcal car-
riage was 0.69 per month (90% CI [0.64, 0.75]). Clear-
ance in adults (≥ 7 years of age) occurred faster, with the
mean relative rate of 1.23 in comparison to children (90%
CI [1.06, 1.42]). In the absence of competing acquisition
from other serotypes, the posterior predictive mean dura-
tion of carriage in children would thus be 39 days in con-
trast to only 32 days in adults. In the posterior predictive
simulations the mean length of a single episode for chil-
dren was 33 days (95%CI [5, 50]), 6 days less than the
implied mean duration in the absence of competition.
Model validation
Figure 1 presents posterior predictions of the frequency
distribution of serotypes in the day care attendees of a sin-
gle day care cohort, together with the actually observed
data from the three cohorts. The serotypes are ranked
according to their prevalence. The predicted and observed
distributions are similar, showing that our model was suc-
cessful in producing the observed pattern. Specifically, the
highly skewed distribution is a consequence of serotype-
specific clustering. Of note, this clustering is produced by
within-cohort transmission and between-serotype compe-
tition even under the assumed exchangeability of sero-
types in terms of their rates of acquisition and clearance.
To distinguish the pattern from clustering produced sim-
ply by ranking the serotypes, a baseline distribution is
shown. The baseline was constructed by assigning ran-
dom serotypes to each episode and then ranking them.
Characteristics of outbreaks
The obvious clustering in the data, reproduced by the
model predictions, indicates that individual serotypes
cause outbreaks of carriage within day care cohorts. The
posterior predictive mean duration of such outbreaks was
2.8 months, with the inter-quartile range [0.9, 3.5]. The
mean number of serotypes carried in a day care cohort at
any time was 7.5, which means that on average 2.7 out-
breaks (new serotypes) are introduced into the cohort
each month. Epidemiologically, a key characteristic of an
outbreak is its size, i.e., the total number of episodes dur-
ing the outbreak [28]. According to the data and our
model, the posterior predictive size of the outbreak has a
skewed, heavy-tailed distribution: 39% of outbreaks were
of size 1 and the mean size was 7.6 episodes, consisting of
5.7 episodes in the day care attendees and 2.0 episodes in
the adult family members. The size of the outbreak
depended on the initial carrier. If the initial carrier was a
child, the average size was 9.6 (7.8 + 1.8), whereas if the
initial carries was an adult, the size was only 5.3 (3.2 +
2.1).
Transmission potential
From posterior predictive simulations, the size of the out-
break in the absence of competition was 46.6 (39.5 + 7.1),
if the initial carrier was a child. The group-to-group repro-
duction number R* (based on children only) calculated
from posterior predictive simulations was 15.8, with a
90% posterior probability to be less than 25. The critical
vaccine efficacy, searched for by simulations, was found to
be 0.3 (Figure 2) and the corresponding child-to-child
reproduction number, inferred via the critical vaccine effi-
cacy, was 1.4.
Discussion
We analysed longitudinal data on pneumococcal carriage
in three cohorts of day care children and their family
members. Rates of pneumococcal acquisition, condi-
tional on serotype specific exposure, were estimated
within a Bayesian framework, utilising latent processes of
carriage in continuous time. To adjust for missing data,
unobserved events of acquisition and clearance were aug-
mented statistically. The results show that pneumococcal
carriage occurs as serotype-specific micro-epidemics, i.e.,
as outbreaks of carriage among day care attendees and
their family members. Transmission within day care cen-
tres is the driving force of pneumococcal transmission in
a population. In particular, outbreaks of pneumococcal
carriage in day care centres cause an amplifying effect that
contributes in maintaining circulation of pneumococci in
the population. For a single pneumococcal serotype, the
group-to-group reproduction number was estimated atBMC Infectious Diseases 2009, 9:102 http://www.biomedcentral.com/1471-2334/9/102
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16, the individual-to-individual reproduction number at
1.4, and the critical vaccine efficacy against carriage at 0.3.
Although the conditional transmission rates within fami-
lies and within day care centres were similar, the role of
families in creating and maintaining micro-epidemics is
minimal. This is due to the smaller size of families in com-
parison to day care centres and to the significantly lower
susceptibility of adults compared to children. Also, as
indicated by the predictive simulations, the day care
attendees were the dominant source in introduction of
new pneumococcal serotypes into the family. This is in
line with [29], where pneumococcal carriage in DCC
attendees was shown to associate with carriage in their
younger siblings.
One of the goals of the present study was to assess the rel-
ative importance of transmission and between-serotype
Model validation Figure 1
Model validation. The cross, diamond, and circle present the observed proportions in the attendees in the three day care 
centres. The proportions are ranked in ascending order. The thick lines denote the 90% posterior predictive intervals of the 
ranked proportions, calculated from a sub-sample of 20 day care attendees. The narrow lines are based on episodes with ran-
dom serotypes, showing the "baseline" distribution that results from ranking only. The posterior predictions were based on 
1000 simulations of a day care centre cohort consisting of 50 day care attendees and their family members. The size of the 
three DCCs as the number of day care attendees together with the number of participating attendees is given in the parenthe-
sis.BMC Infectious Diseases 2009, 9:102 http://www.biomedcentral.com/1471-2334/9/102
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competition in shaping the clustered pattern of carriage.
We showed that both intense within day care transmis-
sion and competition are needed. In particular, model
simulations showed that mere transmission in the
absence of competition produces too large outbreaks
(mean outbreak size 46.6, in comparison to 9.6 in the
presence of competing serotypes). The role of competition
in our model was thus to limit the size of outbreaks
through reduced duration of carriage, due to acquisition
of other serotypes.
Serotype-specific clustering of pneumococcal carriage
within day care cohorts implies that contact rates are
larger among individuals within the same cohort than
between individuals from different cohorts. Pneumococ-
cal transmission can then be viewed as occurring among a
community of day care centres in terms of the idea of
group-to-group transmission. In such a set-up, [27]
derived threshold parameters for eliminating endemic cir-
culation of a highly infectious agent by considering prolif-
eration of infected individuals or households. In [21] an
The critical vaccine efficacy Figure 2
The critical vaccine efficacy. The group-to-group reproduction number   under vaccination in a population of day care 
cohorts of equal size, for different values of vaccine efficacy against acquisition. For each line the size of the day care cohort is 
given as the number of day care attendees (50, 30, and 20). The entire cohort including family members were used in the sim-
ulations. In each simulation roughly half of the day care attendees had a sibling attending the same day care centre, i.e., one 
third of the families had two children in the day care centre and two thirds of the families had one child in the day care centre.
Rn
∗BMC Infectious Diseases 2009, 9:102 http://www.biomedcentral.com/1471-2334/9/102
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analogous threshold theorem was derived for an infection
that does not confer immunity against re-infection (cf.
pneumococcal carriage). We applied the latter approach
to determine the basic reproduction number for the pro-
liferation of day care centres that carry a specific serotype.
Assuming a homogeneous size of the DCC (N = 50) we
found that R* was 16.
We then asked what is the critical efficacy against pneu-
mococcal acquisition for elimination of a specific sero-
type, if all day care attendees were to be vaccinated. The
critical vaccine efficacy νc was found to be 0.3, which
means that although the serotype specific R* appears
large, vaccination works very effectively in a clustered set-
up. The explanation is that in addition to reducing suscep-
tibility to pneumococcal carriage in individuals, vaccina-
tion induces a herd effect on transmission within DCCs,
thus creating a counter-effect to the amplifying effect of
the cohort. As shown in Figure 2, the critical vaccine effi-
cacy is robust to the size of the DCC. Figure 2 can also be
used to assess the dependence of the critical vaccine effi-
cacy on the estimate of rate λ (0.31 per month), at which
a child transmits carriage to outside its own day care
cohort. Specifically, if this rate is an over-estimate, e.g. half
of the actual value, the critical vaccine efficacy is read from
the intersection with line R* = 0.5, implying somewhat
higher values for the critical efficacy. If λ is an under-esti-
mate, the critical efficacy would be lower than 0.3, with
some heterogeneity according to the assumed group size.
The individual-to-individual basic reproduction number
for a pneumococcal serotype was estimated as 1.4. This
low reproduction number corresponds well to an SIS type
of infection (pneumococcal carriage) [30,31], for which
the required vaccination effort is typically of the order of
the prevalence of infection. Thus, for a typical serotype
with prevalence of the order of 10% at maximum, the
number is actually quite large, describing the transmis-
sion potential in the absence of competition by other
serotypes. As the individual-to-individual basic reproduc-
tion number is a direct function of the critical vaccine effi-
cacy, its assessment is also robust to the size of the DCC.
In addition, competition by non-vaccine serotypes would
induce a beneficial effect, thus implying an even smaller
critical efficacy against carriage.
The observed serotype distribution was slightly more clus-
tered than that produced by posterior predictive esti-
mates. A possible explanation is the existence of sub-
groups, classes, within each day care centre, which was not
considered in the model. DCC1 and DCC3 consisted of
two classes and DCC2 of three classes. The data for some
serotypes suggest that transmission within the sub-groups
is higher than between the sub-groups, although this was
not consistent over serotypes and day care centres (data
not shown). Another explanation for the even stronger
clustering in the observed data is the simplifying assump-
tion of a constant community exposure over the follow-
up time period. It is likely that community exposure to the
included serotypes was temporally heterogeneous, thus
increasing clustering.
Within each day care cohort the analysis considered 13
serotypes only, which was the maximum number of sero-
types found in a single cohort. We experimented also with
a model were all 21 serotypes found in the present study
were taken into account in each cohort. Due to the
assumption of equal rates, the overall community force of
infection divides equally between all serotypes, thus
resulting in a smaller community acquisition rate per
serotype. However, the model validation with revealed a
poor fit for this model, with too many serotypes present
and too little clustering.
Only 21 out of the 91 serotypes were observed during the
follow-up. Especially there were no isolates of serotype
23F, which was one of the most prevalent serotypes in a
contemporaneous study from the same geographical area.
Due to the high transmission rate within the day care
cohorts, samples within a cohort are highly correlated.
Thus the effective sample size to determine the serotype
distribution is much smaller than the number of samples.
However, we hypothesise that by sampling a large
number of day care cohorts we would have encountered
micro-epidemics of other serotypes and the overall sero-
type distribution would have resembled that of the popu-
lation.
The assumption of identical parameter values for all sero-
types goes against the general understanding that sero-
types have different transmission properties and is thus a
possible limitation of the study. The main reason to treat
all serotypes as identical in the present study is that this
approach significantly reduces the number of parameters,
while still allowing for 1) comparisons between within-
family and within day care exposure, 2) the inspection of
age dependency in susceptibility of acquisition and dura-
tion or carriage, and 3) quantification of competition
between serotypes. However, in the interpretation of the
results one should keep in mind that the results represent
the average behaviour of the observed serotypes and in
reality there may be differences that our model is not able
to address. Obviously, this could apply also to serotype
23F and other usually carried serotypes, not prevalent in
the sample of the present study, although we do not con-
sider this likely.
The statistical analysis in this study that did not take into
account the non-participants resulted in a higher commu-
nity acquisition parameter (mean value 0.0082 in com-BMC Infectious Diseases 2009, 9:102 http://www.biomedcentral.com/1471-2334/9/102
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parison to 0.0059). This reflects the fact that including
more people into the cohort allows acquiring the same
amount of acquisition from outside of the cohort with a
smaller community acquisition value. A similar bias was
evident in an approach where the non-participant DCC
attendees were included into the analysis but their family
members were left out. Also in this approach during the
MCMC estimation the prevalence of pneumococcal car-
riage in the non-participant DCC attendees was consist-
ently lower than that of the participating DCC attendees
(calculated from the latent processes). The reason is that
the non-participant DCC attendees where not exposed by
their families, which led to underestimation of the true
level of exposure.
Our model did not take into account all factors that are
known to affect pneumococcal carriage. For example, res-
piratory infections are known to be associated with
increased acquisition of carriage and antibiotic treatment
temporarily reduces carriage. However, the aim of the cur-
rent analysis was to describe natural pneumococcal trans-
mission in young children, for which exposure to
pneumococci is by far the most important "risk factor"
[17]. The results of our analysis describe the micro-epi-
demic pattern of carriage in a population with a relatively
low use of antibiotics.
The efficacy of the pneumococcal conjugate vaccines
against most vaccine types (serotypes included in the vac-
cines) has been estimated to be about 0.5 (e.g. [9,32]),
which surpasses the critical vaccine efficacy (0.3) inferred
in our study. We therefore conclude that in the present set-
ting conjugate vaccines would be efficacious enough to
eliminate carriage of at least most vaccine serotypes. Fur-
ther, as carriage is a pre-requisite of pneumococcal dis-
ease, our results predict that herd protection, provided by
elimination of transmission, is on its own sufficient to
eliminate the majority of pneumococcal disease caused by
the vaccine serotypes.
Our results describe the dynamics of natural carriage in
day care cohorts in Finland. The results as such may not
be directly applicable to countries with different epidemi-
ology of pneumococccal carriage, i.e., with higher preva-
lence carriage. However, similar models based on the
community structure can be used to assess the importance
of group-to-group transmission on pneumococcal car-
riage and its elimination.
Conclusion
Both within-DCC transmission and between-serotype
competition play an important role in shaping micro-epi-
demic transmission of pneumococcal serotypes. The birth
and expansion of outbreaks of carriage within day care
cohorts are enabled by the intense within-group transmis-
sion. Competition by other serotypes restricts the size of
outbreaks. The amplifying effect of day care cohorts, char-
acterised by the mean size of an outbreak, promotes the
spread of pneumococcal serotypes within a population.
Although the size of the DCC has a large effect on the
reproduction number, its impact on the critical vaccine
efficacy is small. In a population of DCCs, the vaccine effi-
cacy against acquisition of carriage, needed to eliminate
transmission of an individual serotype in the absence of
competing serotypes, was estimated as 0.3 only, which
will translate to a strong herd protection against pneumo-
coccal disease.
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Appendix
The complete data likelihood function
For individual i, denote by   the set of times the car-
riage status changes from state r to state s in the time inter-
val ]tmin,  tmax], where tmax is the day after the last NP
sample in the data is taken. Let Ti = { , r, s = 1,...,ns} be
the collection of all times individual i changes carriage sta-
tus. The likelihood function for n individuals on the time
interval ]tmin, tmax] defined by model (1) is
where the unknown model parameters are gathered into
the vector θ = {βfam, βdcc, κ, μ, φ, η, δ} [33]. Within each
day care cohort the transmission of 13 serotypes (ns = 13)
was considered, which was the maximum number of sero-
types observed in one day care cohort during the follow-
up.
Prior distributions
The prior distribution of the community acquisition rate
κ, the within-family transmission rate βfam, the within-
DCC transmission rate βdcc, and the clearance parameter μ
were assigned a normal distribution with mean zero and
standard deviation 3000 (rate per month), constrained to
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positive values only. The relative acquisition rate η and
the relative clearance rate δ were both assigned a uniform
prior on the interval [0,10]. For the competition parame-
ter φ we assumed a prior proportional to φ-1, reflecting
equal prior probabilities for the events φ < 1 and φ < 1. In
addition the probability to carry a serotype at the begin-
ning of the follow up was fixed to 0.25 for the day care
attendees and to 0.10 for the others. The maximum
number of carriage episodes per individual was set to 10.
The non-participants
To ensure the correct contact structure and level of expo-
sure, the non-participating members of the day care
cohort were included in the statistical analysis. These
included the ten family members of participating day care
attendees that had no observations during the follow-up.
In addition, carriage histories were augmented for 77 non-
participating day care attendees and their family mem-
bers. The family size of the non-participating day care
individuals was assumed to be four according to the mean
reported family size. Also in line with the observed data,
half of the non-participating day care attendees were
assumed to have a sibling in the same day care. This
resulted in augmenting 9(7), 51(38), and 27(20) day care
attendees (families) in DCC1, DCC2, and DCC3, respec-
tively. Thus the analyses are based on 213 participants (at
least one NP sample) and 270 non-participants (no NP
samples).
Since no measurements were available from the non-par-
ticipating individuals, their carriage histories relied solely
on the model parameters and on the carriage histories of
the participating members. Therefore, in the parameter
estimation step of the Markov chain Monte Carlo
(MCMC) algorithm an ad hoc approach (cf. the "cut" func-
tion in WinBUGS User Manual [34]) was adopted, where
the information flow from the non-participants was dis-
carded, i.e., the likelihood function (2) was calculated as
a product over the participants only. The non-participants
were taken into account in determining exposure to pneu-
mococci in the participants.
The Markov chain Monte Carlo (MCMC) algorithm
The MCMC algorithm used to produce estimates of the
model parameters was tailor-made using Matlab (version
7.5). The sketch of the MCMC algorithm is as follows:
1. Initialise model parameters θ
2. Initialise latent processes
3. Update parameters θ
a. one at a time, update κ, β and μ
b. update η and δ as a block
4. Update latent processes for a random sample of 20% of
the individuals
a. propose a new episode as described below →
accept/reject proposal
b. propose moving an event time → accecpt/reject pro-
posal
5. Iterate steps 3 and 4 for a predefined number of rounds
In total the MCMC algorithm was run for 15000 rounds
after 5000 burn-in rounds.
Updating the latent processes: proposing a new episode
In the MCMC algorithm for each individual we first ini-
tialise a path consistent with the observed panel data. The
path Hi of individual i consists of the carriage status at
time t0 and a series of events times, acquisition/clearance
times Ti, together with the corresponding event types.
At each MCMC round the path of a chosen individual is
updated by the following algorithm.
1. Choose randomly one of the sampling intervals [Sv,
Sv+1], v = 1,...,(N - 1), where S1 and SN are the beginning
and the end of the follow-up, and S2,...,SN-1 are the indi-
viduals sampling times in ascending order.
2. Within the chosen sampling interval choose randomly
an episode [tk, tk+1], k = 1,...,(M - 1), where t1 = Sv and tN =
Sv+1 are the beginning and the end of the interval, and
t2,...,tM-1 are the individual's acquisition/clearance times
within the interval in ascending order.
3. Define conjoin probabilities Pleft  and  Pright  (needed
later)
a. if Sv = tk, then Pleft = 0, otherwise Pleft = 0.5
b. if Sv+1 = tk+1, then Pright = 0, otherwise Pright = 0.5
4. Propose limits [ ,  ] for a new episode
a. with probability (1 - Pleft)(1-Pright), pick randomly
,  ∈ [tk, tk+1], so that   <
b. with probability PleftPright,   =  tk and   =  tk+1
% t1 % t2
% t1 % t2 % t1 % t2
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c. with probability (Pleft)(1 - Pright),   =  tk and pick ran-
domly   ∈ ]tk, tk+1]
d. with probability (1 - Pleft)(Pright), pick randomly 
∈ [tk, tk+1[ and   = tk+1
5. Propose a "sero"type for the new episode
a. if episode [t, tk+1] is non-carriage episode, propose a
serotype randomly from the ns possibilities
b. if episode [tt, tk+1] is carriage of one of the serotypes,
propose a non-carriage episode
6. Merge similar types
a. if   = tk, and the "sero"type of the proposed epi-
sode and the previous episode are the same, merge the
episodes, i.e.,   = tk-1
b. if   = tk+1, and the "sero"type of the proposed epi-
sode and the following episode are the same, merge
the episodes, i.e.,   = tk+2
7. In order to calculate the probabilities of the back-pro-
posal we define   and 
a. if Sv =  ,   = 0, else   = 0.5
b. if Sv+1 =  ,   = 0, else   = 0.5
8. Accept the proposed episode with probability
Where Hi and   are the present and the proposed path
(history) for individual i, Mi is the observed data for indi-
vidual i, P is the prior of the complete data (the likelihood
function of the model parameters), Pc is the likelihood
function of the complete data (is one if the complete data
is consistent with the observed data and is zero other-
wise), and Q(u|v) is the probability of proposing path u
given path v. The exact form of Q can be derived from
steps 1 to 7. For example, if we propose to add a carriage
episode [ ,  ] within a non carriage episode [tk, tk+1],
where tk < < < tk+1, the proposal probability is
and the back proposal probability is
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